Objective: Few studies have explored Australian women's understandings of contraception. This study examined the attitudes towards, and understandings of, the subdermal contraceptive implant expressed by women living in New South Wales (NSW), Australia.
Study Design: As part of a larger qualitative study using in-depth, open-ended interviews in 2012-2013 with women aged 16-49 years who had ever used contraception (=94), 65 interviews from women who discussed or mentioned the subdermal implant, but had not previously used the device, were examined and analysed using thematic analysis.
Results: The emergent themes were: satisfaction with current method; weak personal opinions and ambivalence; uncertainty due to specific concerns; and strong negative reactions - fear and dislike. Although there were a few positive perceptions expressed by women who had never used the subdermal implant, for the majority of women the perception was predominantly negative.
Discussion And Conclusion: Women tended to form negative impressions from the stories of other women about the subdermal implant. Interventions to enhance evidence-informed awareness of the relative advantages and disadvantages of the implant - for example, improved access to supportive contraceptive counselling - need investigation in the Australian context. Avenues to improve women's perceived control over the device could also be usefully investigated.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1136/jfprhc-2014-101132 | DOI Listing |
Eur J Contracept Reprod Health Care
December 2024
Department of Obstetrics and Gynecology, Faculty of Medicine, University of São Paulo, Osasco, São Paulo, Brazil.
Objective: To analyse the understanding of deaf women regarding contraceptive methods.
Method: We conducted a qualitative descriptive study in two referral centres for sexual and reproductive health (SRH) in São Paulo, Brazil, trough years 2020-2022. Twenty-eight deaf women who use Brazilian Sign Language (LIBRAS) were interviewed face-to-face and remotely via videocall using a semi-structured questionnaire containing sociodemographic and clinical data and questions about understanding and knowledge of contraceptive methods.
Pharm Nanotechnol
December 2024
Department of Pharmaceutics, SRM College of Pharmacy, SRMIST, Kattankulathur-603203, Tamil Nadu, India.
Background: The necessity for extended drug discharge to alleviate pain without adverse effects underscores the importance of innovative drug delivery systems. Achieving sustained pain relief without compromising patient safety is a critical objective in healthcare. By extending the duration of drug action while suppressing side effects, such systems offer enhanced therapeutic outcomes and improved patient quality of life.
View Article and Find Full Text PDFHematology Am Soc Hematol Educ Program
December 2024
Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Hormonal contraceptive therapy (estrogens and/or progestogens) includes different formulations associated with varying venous thromboembolism (VTE) risks. The thrombogenicity of combined hormonal contraceptives (CHCs) is due at least in part to multiple changes in clotting factors and the vasculature and is dependent on both estrogen dose and type of progestin. Transdermal patch and vaginal ring users have similar or higher VTE risk as combined oral contraceptive users.
View Article and Find Full Text PDFNeuroscience
January 2025
Department of Psychology, Concordia University, Montreal, Canada. Electronic address:
Quant Imaging Med Surg
November 2024
Department of Radiology (CDI), Hospital Clinic of Barcelona, University of Barcelona (UB), Barcelona, Spain.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!